SofMedica

SOFMEDICA GROUP is present in Europe since 1994. With offices and operations in Romania, Greece, Hungary, Bulgaria & Cyprus, the Group focuses in five major business lines:

SOFMEDICA – Life Saving Innovation
Providing Innovation that saves lives
Making Life Saving Technologies available to the Remotest Patient in Europe by empowering the Healthcare Professionals with the most reliable Ecosystem of Innovation & Learning.

ISLE ACADEMY – Innovation, Simulation & Learning Ecosystem
Life-Long Learning for Healthcare Professionals
Creating an open-source ecosystem for Healthcare Professionals in order to make innovation and life-long learning an essential part in their professional development.

EMERALD – Precious Healthcare
Patient-Centered Medical Center
Treating, preventing & predicting Heart and Brain pathologies. Aiming to deliver the best quality medical services available for those with cardiovascular and neurological conditions through our expert personnel, sophisticated integrated system, high-tech equipment, personalized customer service and wide network of centers.

MEDCITY – The Medical Mall 
Healthcare Building Expertise & Development
Aiming to further expand the network of medical dedicated buildings, in South-eastern Europe by offering healthcare operators & patients highest standards medical facilities according to the international standards & good practice.

MEDI LEASING – Innovation at Your Fingertips
Financing Innovation requiring capital expenditure
Providing tailored financing programs that meet modern healthcare requirements by accessing a robust portfolio of high-end medical technologies.

With the combined power of technological Innovation, lifelong Education and human Passion we enable HCPs and provide Patients with the best healthcare available in the world – regardless of their social or financial status.

We fight the top life-threatening diseases: cancer, cardiovascular and neuro-degenerative diseases. And we are winning by ensuring early & precise diagnosis on the one hand and innovative therapies with minimal impact on Patients’ lives on the other.